Literature DB >> 23001723

Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.

Qin Fan1, Minyi He, Xinjun Deng, William K K Wu, Liang Zhao, Jing Tang, Ge Wen, Xuegang Sun, Yawei Liu.   

Abstract

This study investigates whether the anti-metastasis effect of microRNA-139 (miR-139) on hepatocellular carcinoma (HCC) is mediated through regulating c-fos expression. The expression levels of miR-139 and c-fos in human HCC cell sublines with high (MHCC97H) and low (MHCC97L) spontaneous metastatic potentials were quantified using QPCR or Western blot. miR-139 mimics was transfected into MHCC97H cells to overexpress miR-139, and miR-139 inhibitor was transfected into MHCC97L cells to down-express miR-139. The effect of overexpression or down-expression of miR-139 on c-fos expression of MHCC97H and MHCC97L cells was evaluated using QPCR and Western blot. The 3' untranslated region segments of FOS containing the miR-139 binding sites were amplified by PCR, and the luciferase activity in the transfected cells was assayed. In comparison with the expression level of miR-139 in MHCC97L cells, the expression level in MHCC97H cells was significantly decreased, whereas c-Fos was significantly up-regulated in MHCC97H. The overexpression of miR-139 significantly inhibited the expression of c-fos in MHCC97H cells, and the down-expression of miR-139 significantly promoted the expression of c-fos in MHCC97L cells. miR-139 suppressed the luciferase activity of the pGL-FOS by approximately 40% compared with the negative control. In vitro cell migration analysis demonstrated that depletion of c-fos or overexpression of miR-139 in MHCC97H cells reduced cell migration, whereas overexpression of c-fos or depletion of miR-139 in MHCC97L cells increased cell migration. Thus, we got the conclusion that miR-139 expression is down-regulated in human HCC cell sublines with high spontaneous metastatic potentials (MHCC97H). Derepression of c-Fos caused by miR-139 down-regulation contributes to the metastasis of HCC.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001723     DOI: 10.1002/cbf.2902

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  43 in total

1.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

Review 2.  Epigenetics of hepatocellular carcinoma: role of microRNA.

Authors:  Sharad Khare; Qiong Zhang; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

3.  Integrated microRNA and mRNA responses to acute human left ventricular ischemia.

Authors:  Louis A Saddic; Tzuu-Wang Chang; Martin I Sigurdsson; Mahyar Heydarpour; Benjamin A Raby; Stanton K Shernan; Sary F Aranki; Simon C Body; Jochen D Muehlschlegel
Journal:  Physiol Genomics       Date:  2015-07-14       Impact factor: 3.107

Review 4.  [Research progress of miRNAs targeting GSK-3β in regulation of hepatocellular carcinoma invasion and metastasis].

Authors:  Song-Qi He; Bin Wen; Guan-Xin Chen; Hai-Tao Sun; Jia-Ling Sun; Xue-Mei Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

5.  The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility.

Authors:  Bassem D Khalil; Samer Hanna; Bechara A Saykali; Sally El-Sitt; Anita Nasrallah; Daniel Marston; Marwan El-Sabban; Klaus M Hahn; Marc Symons; Mirvat El-Sibai
Journal:  Exp Cell Res       Date:  2013-12-10       Impact factor: 3.905

6.  Analysis of expression profile data identifies key genes and pathways in hepatocellular carcinoma.

Authors:  Xuwei Jiang; Yuqing Hao
Journal:  Oncol Lett       Date:  2017-12-06       Impact factor: 2.967

7.  MicroRNA-139-3p indicates a poor prognosis of colon cancer.

Authors:  Xiaojing Liu; Bensong Duan; Yuanyuan Dong; Chengzhi He; Hongmei Zhou; Haihui Sheng; Hengjun Gao; Xizhi Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 8.  MiR-139-5p: promising biomarker for cancer.

Authors:  He-da Zhang; Lin-hong Jiang; Da-wei Sun; Jian Li; Jin-hai Tang
Journal:  Tumour Biol       Date:  2015-02-19

9.  miR-139-5p controls translation in myeloid leukemia through EIF4G2.

Authors:  S Emmrich; F Engeland; M El-Khatib; K Henke; A Obulkasim; J Schöning; J E Katsman-Kuipers; C Michel Zwaan; A Pich; J Stary; A Baruchel; V de Haas; D Reinhardt; M Fornerod; M M van den Heuvel-Eibrink; J H Klusmann
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

Review 10.  Alcoholic and non-alcoholic steatohepatitis.

Authors:  Manuela G Neuman; Samuel W French; Barbara A French; Helmut K Seitz; Lawrence B Cohen; Sebastian Mueller; Natalia A Osna; Kusum K Kharbanda; Devanshi Seth; Abraham Bautista; Kyle J Thompson; Iain H McKillop; Irina A Kirpich; Craig J McClain; Ramon Bataller; Radu M Nanau; Mihai Voiculescu; Mihai Opris; Hong Shen; Brittany Tillman; Jun Li; Hui Liu; Paul G Thomes; Murali Ganesan; Steve Malnick
Journal:  Exp Mol Pathol       Date:  2014-09-11       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.